Navila Rehman has joined Boyds as Submissions Compliance and Quality Manager within the regulatory affairs team.
Navila brings over 20 years’ experience in the pharmaceutical industry with a primary focus on quality systems and regulatory operations.
Qualified with a BSc in Pharmaceutical Management, Navila has held a number of roles including Quality Systems Manager at Gregory Fryer Associates, QA Executive at Tillomed Laboratories, and most recently Senior Principal Consultant at Onix Life Sciences where she led a team of publishers and was responsible for the submission of technically valid applications to global health authorities.
Navila will be supporting both the regulatory and clinical teams at Boyds to ensure consistently high-quality client submissions are made to the regulatory agencies, including the MHRA, EMA and FDA. The newly created role will also involve the further development of in-house quality procedures in line with the relevant regulatory requirements.
Commenting on her appointment, Navila said: “Boyds is a prestigious and reputable company offering innovative regulatory solutions, and I am very excited to be part of the growing and highly experienced team.”
Dr Julie Warner, Vice President of Regulatory Affairs, added: “We continue to experience consistent growth in demand for our regulatory services, particularly in the specialist areas of ATMPs, including many cell and gene therapies and, more recently, COVID treatments and vaccines. In addition, we are supporting clients with the regulatory guidance and processes now the Brexit transition has come to an end.
“In 2020 we grew the team to bring in more expertise to support our growing client base, and have further appointments planned in 2021. Navila brings a huge amount of experience to the newly created role and will help support many projects across Boyds as well as introducing and improving our processes. We are delighted to have her on the team.”
